NKG2D-L
Showing 26 - 50 of >10,000
Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6
Withdrawn
- Recurrent Diffuse Large B-Cell Lymphoma
- +9 more
- Autologous Hematopoietic Stem Cell Transplantation
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))
Suspended
- Gastroenteropancreatic Neuroendocrine Tumor
- Lutathera
- +4 more
-
Stanford, CaliforniaStanford Cancer Institute Palo Alto
Sep 21, 2022
B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Biospecimen Collection
- +19 more
- (no location specified)
Nov 8, 2023
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia
Not yet recruiting
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Biospecimen Collection
- +12 more
- (no location specified)
Mar 8, 2023
NSCLC, Progression of NSCLC, NSCLC Recurrent Trial in Saint Louis, Cincinnati (Docetaxel, Tergenpumatucel-L, Indoximod)
Terminated
- Non-small Cell Lung Cancer
- +2 more
- Docetaxel
- +2 more
-
Saint Louis, Missouri
- +1 more
Apr 4, 2022
Early On-treatment Transcriptional Profiling as Predictor of
Recruiting
- HER2-positive Breast Cancer
- +2 more
- Trastuzumab (neoadjuvant)
- +2 more
-
Hospitalet de Llobregat, Barcelona, SpainInstitut Català d'Oncologia l'Hospitalet
Jun 12, 2023
HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,
Recruiting
- HIV Infection
- +10 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
La Jolla, California
- +3 more
Dec 7, 2022
Long-Term Development of Muscular Dystrophy Outcome Assessments
Not yet recruiting
- LGMD1A
- +33 more
-
Richmond, VirginiaVirginia Commonwealth University
Aug 3, 2023
Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,
Recruiting
- Autoimmune Disease
- +18 more
- Anti-Thymocyte Globulin
- +9 more
-
Denver, Colorado
- +2 more
Feb 1, 2023
Type 1 Diabetes (T1D) Trial in Gainesville (L. johnsonii Probiotic, Placebo Capsule)
Recruiting
- Type 1 Diabetes (T1D)
- L. johnsonii Probiotic
- Placebo Capsule
-
Gainesville, FloridaUF Clinical Research Center
Sep 26, 2022
Stroke, Acute Brain Injury Trial in Kingston (Dynavision D2)
Not yet recruiting
- Stroke
- Acute Brain Injury
- Dynavision D2
-
Kingston, Ontario, CanadaProvidence Care Hospital
Aug 16, 2022
Urinary Retention, Colorectal Surgery, Rectal Resection Trial in Québec (pr Sandoz Tamsulosin, Glucose)
Not yet recruiting
- Urinary Retention
- +4 more
- pr Sandoz Tamsulosin
- Glucose
-
Québec, Que, Canada
- +1 more
Jul 4, 2023
Transient Hypercalciuria Trial in Montpellier, Nîmes (Cholecalciferol sequential dose, Cholecalciferol daily dose)
Recruiting
- Transient Hypercalciuria
- Cholecalciferol sequential dose
- Cholecalciferol daily dose
-
Montpellier, France
- +1 more
Dec 20, 2021
T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)
Recruiting
- T Acute Lymphoblastic Leukemia
- T Lymphoblastic Lymphoma
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Jan 11, 2023
Breast Cancer Trial (dalpiciclib plus letrozole)
Not yet recruiting
- Breast Cancer
- dalpiciclib plus letrozole
- (no location specified)
Aug 21, 2022
Unresectable Metastatic Colorectal Cancer Trial in Belgium, United States (CYAD-101, FOLFOX, FOLFIRI)
Recruiting
- Unresectable Metastatic Colorectal Cancer
- CYAD-101
- +2 more
-
Tampa, Florida
- +3 more
Nov 19, 2020
Disease Activity in Canadian Adult Moderate-to-Severe Atopic
Recruiting
- Atopic Dermatitis
-
Calgary, Alberta, Canada
- +17 more
Jan 17, 2023
Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia
Recruiting
- Recurrent B Acute Lymphoblastic Leukemia
- +3 more
- Cyclophosphamide
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2022
N-13 Ammonia Safety Trial in Montréal (N-13 ammonia intravenous injection)
Recruiting
- N-13 Ammonia Safety
- N-13 ammonia intravenous injection
-
Montréal, Quebec, CanadaCentre Hospitalier de l'université de Montréal
Aug 5, 2022
Measurement Information System-29 v2.1 for Postpartum Women
Not yet recruiting
- Well-Being, Psychological
- PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System)
- +2 more
-
Toronto, Ontario, CanadaMount Sinai Hospital
Aug 16, 2023
Covid19 Trial in Örebro (L. reuteri DSM 17938 + vitamin D, Placebo + vitamin D)
Completed
- Covid19
- L. reuteri DSM 17938 + vitamin D
- Placebo + vitamin D
-
Örebro, Örebro Län, SwedenÖrebro University
Oct 14, 2021
Failure in Metastatic Colorectal Cancer Patients
Recruiting
- Colorectal Cancer Metastatic
-
Montreal, Quebec, CanadaCentre hospitalier de l'Université de Montréal (CHUM)
Nov 11, 2022
Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)
Not yet recruiting
- Squamous Cell Carcinoma
- Oral Cavity Squamous Cell Carcinoma
- Tiragolumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2023
Depression, Cognitive Impairment, Gait Impairment Trial in New York (Carbidopa/levodopa, Placebo)
Suspended
- Depression
- +2 more
- Carbidopa/levodopa
- Placebo
-
New York, New YorkNew York State Psychiatric Institute
Jan 26, 2022